Anna Plym

Biography

I am a prostate cancer researcher and epidemiologist with joint appointments at Harvard T.H. Chan School of Public Health, Brigham and Women's Hospital, and Karolinska Institutet. My research aims at improving genetic risk stratification for prostate cancer, in particular aggressive disease, and at understanding if a high genetic risk can be offset by adherence to a healthy lifestyle.

Education and Training

• MSc, Biomedical Science
  Uppsala University
• MSc, Public Health Epidemiology
  Karolinska Institutet
• PhD, Cancer Epidemiology
  Karolinska Institutet
• Postdoc, Genetic Epidemiology
  Harvard T.H. Chan School of Public Health, Brigham and Women's Hospital

Awards and Honors

• Young Investigator Award, Prostate Cancer Foundation (PCF), 2021
• Scholar-in-Training Award, American Association for Cancer Research, 2021

Publications

• Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial.

  Vigneswaran HT, Eklund M, Discacciati A, Nordström T, Hubbard RA, Perlis N, Abern MR, Moreira DM, Eggener S, Yonover P, Chow AK, Watts K, Liss MA, Thoreson GR, Abreu AL, Sonn GA, Palsdottir T, Plym A, Wiklund F, Grönberg H, Murphy AB. J Clin Oncol 2024 Nov 10

• Early Prostate Cancer Deaths Among Men With Higher vs Lower Genetic Risk.

  Plym A, Zhang Y, Stopsack KH, Ugalde-Morales E, Seibert TM, Conti DV, Haiman CA, Baras A, Stocks T, Drake I, Penney KL, Giovannucci E, Kibel AS, Wiklund F, Mucci LA. JAMA Netw Open 2024 Jul 01

• Healthy lifestyle and prostate cancer risk in the Million Veteran Program.

  Pagadala MS, Lui A, Lynch J, Karunamuni R, Lee KM, Plym A, Rose BS, Carter H, Kibel AS, DuVall SL, Vassy J, Gaziano JM, Panizzon MS, Hauger RL, Seibert TM. Cancer 2024 Oct 15

• Agent orange exposure and prostate cancer risk in the million veteran program.

  Pagadala MS, Lui AJ, Zhong AY, Lynch JA, Karunamuni R, Lee KM, Plym A, Rose BS, Carter HK, Kibel AS, DuVall SL, Gaziano JM, Panizzon MS, Hauger RL, Seibert TM. Acta Oncol 2024 May 23

• Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer.

  Rumpf F, Plym A, Vaselkiv JB, Penney KL, Preston MA, Kibel AS, Mucci LA, Salari K. J Urol 2024